Cargando…

A Report on Children with CEP290 Mutation, Vision Loss, and Developmental Delay

Mutations in CEP290, which encodes a centrosomal protein, cause Joubert syndrome, retinal dystrophy, and several other manifestations. Retinal dystrophy related to CEP290 mutation (Leber’s congenital amaurosis type 10) presents with a severe visual impairment from birth, wandering eye movements, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahli, Esra, Kiziltunc, Pinar Bingol, Idil, Aysun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521126/
https://www.ncbi.nlm.nih.gov/pubmed/37766766
http://dx.doi.org/10.14744/bej.2023.37233
_version_ 1785110067718127616
author Sahli, Esra
Kiziltunc, Pinar Bingol
Idil, Aysun
author_facet Sahli, Esra
Kiziltunc, Pinar Bingol
Idil, Aysun
author_sort Sahli, Esra
collection PubMed
description Mutations in CEP290, which encodes a centrosomal protein, cause Joubert syndrome, retinal dystrophy, and several other manifestations. Retinal dystrophy related to CEP290 mutation (Leber’s congenital amaurosis type 10) presents with a severe visual impairment from birth, wandering eye movements, and oculodigital reflex. Fundus examination may initially be normal, but varying degrees of retinal pigmentation can be detected over time. This report presents 4 children who were referred to the ophthalmology clinic with a lack of eye contact and the suspicion of low vision. The ophthalmological examination revealed very poor visual function, the vision slightly improved over time, and enophthalmos became evident. There was neuromotor retardation in their history and mutations in the CEP290 gene were revealed in the whole-exome analysis. Both pediatricians and ophthalmologists should be aware of the coincidence between severe vision loss and neuromotor retardation and should refer patients for genetic testing if they suspect it. Genetic diagnosis will enable patients to be followed both neurologically and ophthalmologically and to benefit from rehabilitation opportunities that will contribute to visual and neurological development. It will also allow the family to receive genetic counseling on disease progression and heredity, and to follow ongoing gene therapy studies for mutations in the relevant gene.
format Online
Article
Text
id pubmed-10521126
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Kare Publishing
record_format MEDLINE/PubMed
spelling pubmed-105211262023-09-27 A Report on Children with CEP290 Mutation, Vision Loss, and Developmental Delay Sahli, Esra Kiziltunc, Pinar Bingol Idil, Aysun Beyoglu Eye J Case Report Mutations in CEP290, which encodes a centrosomal protein, cause Joubert syndrome, retinal dystrophy, and several other manifestations. Retinal dystrophy related to CEP290 mutation (Leber’s congenital amaurosis type 10) presents with a severe visual impairment from birth, wandering eye movements, and oculodigital reflex. Fundus examination may initially be normal, but varying degrees of retinal pigmentation can be detected over time. This report presents 4 children who were referred to the ophthalmology clinic with a lack of eye contact and the suspicion of low vision. The ophthalmological examination revealed very poor visual function, the vision slightly improved over time, and enophthalmos became evident. There was neuromotor retardation in their history and mutations in the CEP290 gene were revealed in the whole-exome analysis. Both pediatricians and ophthalmologists should be aware of the coincidence between severe vision loss and neuromotor retardation and should refer patients for genetic testing if they suspect it. Genetic diagnosis will enable patients to be followed both neurologically and ophthalmologically and to benefit from rehabilitation opportunities that will contribute to visual and neurological development. It will also allow the family to receive genetic counseling on disease progression and heredity, and to follow ongoing gene therapy studies for mutations in the relevant gene. Kare Publishing 2023-09-13 /pmc/articles/PMC10521126/ /pubmed/37766766 http://dx.doi.org/10.14744/bej.2023.37233 Text en Copyright: © 2023 by Beyoglu Eye Training and Research Hospital https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
spellingShingle Case Report
Sahli, Esra
Kiziltunc, Pinar Bingol
Idil, Aysun
A Report on Children with CEP290 Mutation, Vision Loss, and Developmental Delay
title A Report on Children with CEP290 Mutation, Vision Loss, and Developmental Delay
title_full A Report on Children with CEP290 Mutation, Vision Loss, and Developmental Delay
title_fullStr A Report on Children with CEP290 Mutation, Vision Loss, and Developmental Delay
title_full_unstemmed A Report on Children with CEP290 Mutation, Vision Loss, and Developmental Delay
title_short A Report on Children with CEP290 Mutation, Vision Loss, and Developmental Delay
title_sort report on children with cep290 mutation, vision loss, and developmental delay
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521126/
https://www.ncbi.nlm.nih.gov/pubmed/37766766
http://dx.doi.org/10.14744/bej.2023.37233
work_keys_str_mv AT sahliesra areportonchildrenwithcep290mutationvisionlossanddevelopmentaldelay
AT kiziltuncpinarbingol areportonchildrenwithcep290mutationvisionlossanddevelopmentaldelay
AT idilaysun areportonchildrenwithcep290mutationvisionlossanddevelopmentaldelay
AT sahliesra reportonchildrenwithcep290mutationvisionlossanddevelopmentaldelay
AT kiziltuncpinarbingol reportonchildrenwithcep290mutationvisionlossanddevelopmentaldelay
AT idilaysun reportonchildrenwithcep290mutationvisionlossanddevelopmentaldelay